Advanced LC-MS/MS Technology: A Strategic Partnership with Lablytica

Our strategic partnership with Lablytica Life Science significantly enhances our service offerings with the integration of advanced Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) technology in our GLP-regulated laboratories.

This collaboration allows us to provide comprehensive support for drug development programs across various stages and modalities, ensuring high-quality, reliable data for our clients.

What is LC-MS/MS Technology?

LC-MS/MS is a sophisticated analytical technique that combines the separation capabilities of liquid chromatography (LC) with the mass analysis capabilities of tandem mass spectrometry (MS/MS).

This technology is essential for the precise identification, quantification, and structural elucidation of both small and large molecules in complex biological matrices.

Applications in Drug Development

Preclinical Studies: In the early stages of drug development, LC-MS/MS is used to analyze pharmacokinetics (PK) and pharmacodynamics (PD) in animal models. This technology provides critical data on the absorption, distribution, metabolism, and excretion (ADME) of new drug candidates, ensuring their safety and efficacy before progressing to clinical trials. 

Clinical Trials: During clinical trials, LC-MS/MS supports bioanalysis by quantifying drugs and their metabolites in biological samples from human subjects. This is crucial for determining the drug's behavior in the human body and ensuring compliance with regulatory guidelines such as ICH M10, EMA, and FDA standards. 

Biomarker Discovery: LC-MS/MS is instrumental in identifying and quantifying biomarkers, which are indicators of biological or pathological processes. This helps in understanding disease mechanisms, monitoring therapeutic responses, and developing personalized medicine approaches. 

Exploratory Assays: In the exploratory phase, LC-MS/MS is used to develop and validate new analytical methods. This phase involves initial testing and optimization to ensure the methods are fit for purpose, providing reliable data for early-stage drug discovery.

Advantages of LC-MS/MS

High Sensitivity and Selectivity: LC-MS/MS can detect and quantify low concentrations of analytes in complex biological matrices, making it ideal for both small and large molecule analysis. 

Versatility: This technology is applicable to a wide range of molecules, including peptides, proteins, biologics, and small-molecule drugs. 

Regulatory Compliance: Our partner’s GLP-regulated laboratories ensure that all analyses are conducted in compliance with international regulatory standards, providing reliable and reproducible data. 

High Throughput: Automation capabilities allow for the rapid analysis of large sample sets, ensuring timely delivery of results.

The Expertise

Lablytica’s team of experienced scientists is equipped with state-of-the-art LC-MS/MS platforms, delivering accurate and reliable data for various therapeutic programs. They offer end-to-end support, from method development and validation to sample analysis, ensuring that your drug development program meets the highest standards of quality and compliance. 

Conclusion

The integration of LC-MS/MS technology into our GLP-regulated laboratories marks a significant milestone in our commitment to advancing drug development.
This strategic partnership not only enhances our service offerings but also reinforces our dedication to providing high-quality, reliable data for clinical and non-clinical programs.

We look forward to collaborating with you to achieve your drug development goals.